Intrastriatal lipopolysaccharide injection induces parkinsonism in C57/B6 mice
- 17 February 2009
- journal article
- research article
- Published by Wiley in Journal of Neuroscience Research
- Vol. 87 (8), 1913-1921
- https://doi.org/10.1002/jnr.22012
Abstract
No abstract availableKeywords
This publication has 36 references indexed in Scilit:
- Systemic LPS causes chronic neuroinflammation and progressive neurodegenerationGlia, 2007
- Involvement of inducible nitric oxide synthase in inflammation-induced dopaminergic neurodegenerationNeuroscience, 2001
- Inflammatory Regulators in Parkinson's Disease: iNOS, Lipocortin-1, and Cyclooxygenases-1 and -2Molecular and Cellular Neuroscience, 2000
- The Single Intranigral Injection of LPS as a New Model for Studying the Selective Effects of Inflammatory Reactions on Dopaminergic SystemNeurobiology of Disease, 2000
- Understanding Parkinson's DiseaseScientific American, 1997
- Interleukin-1β, interleukin-6, epidermal growth factor and transforming growth factor-α are elevated in the brain from parkinsonian patientsNeuroscience Letters, 1994
- New stereological methods for counting neuronsNeurobiology of Aging, 1993
- Abnormalities of the electron transport chain in idiopathic parkinson's diseaseAnnals of Neurology, 1989
- Rate of cell death in parkinsonism indicates active neuropathological processAnnals of Neurology, 1988
- A rotarod suitable for quantitative measurements of motor incoordination in naive miceNaunyn-Schmiedebergs Archiv für experimentelle Pathologie und Pharmakologie, 1968